Why Do PD-L1-Negative Patients Respond to PD-1 Blockade? | Cholangio TODAY
PD-L1-negative patients can respond to PD-1 immunotherapy. If the test says negative but the patient responds, what biology did the test fail to capture?
ATM Mutation in Cancer: What It Means and Why Context Matters
ATM mutation in cancer is often misunderstood. This article explains what ATM really means, why it appears, and why biological context matters more than the gene itself.
When the Path is Blocked – Go Around
Just as science has developed immunotherapy drugs to recruit our immune system to fight and defeat cancer, we too can harness and recruit the possibilities within the obstacle of Cholangiocarcinoma to overcome it. While a cancer diagnosis is beyond our control, how we respond and think is entirely within our power.
A Patient Story – From Christmas to Cancer Survival
Experience an inspiring Christmas cancer survival. Learn to lean into life with nothing more than persistence and perseverance
Cycling 10,000 kms for 1,000 Patient Navigational Journals
Support my ride for patient journals: Patient Journals better equip and empower patients, to respond survive an unexpected cancer diagnosis - they bridge the knowledge gap
Translational Genomics and the Empowered Patient:The Linchpin of Cancer Success
Bridging Science and Patients: A Revolution in Cancer Treatment to unlock the power of translational genomics to empower cancer patients.